<div xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../src-generated/schemas/fhir-single.xsd">
  <p>
		The Genomic Implication profile is an abstract profile for therapeutic and diagnostic implications and molecular consequences. 
		Implications are relevant information which are derived from the presence of a haplotype, genotype, variant or molecular biomarker.
	This portion of the implementation guide relies on the content in the <a href="general.html">General Genomic Reporting</a> and <a href="sequencing.html">Variant Reporting</a> portions of this implementation guide.  
  </p>

 <p>
    This profile defines a common set of elements for other Implications:
 </p>
  <ul>
    <li><code>Related Artifact (base extension)</code> supports conveying references to citations, supporting documentation and other information relevant to the asserted implication</li>
    <li><code>evidence-level (component)</code> indicates the strength of the evidence behind the asserted implication</li>
    <li><code>clinical-significance (component)</code> indicates the clinical impact of an implication</li>
  </ul>

	<a name="Evidence-Significance"> </a>
	<h3>evidence-level versus clinical-significance</h3>
	<p><b>evidence-level</b>: The amount of observed support for the association between an implication and a variant / haplotype / genotype / biomarker. 
	There are dozens if not hundreds of evidence-level value sets, generally providing an ordinal range of codes from low evidence 
	(e.g. 'predicted', 'case report', '1-star') to high evidence (e.g. 'professional society guideline', 'expert panel consensus', '1A'). </p>
	<p><b>clinical-significance</b>: The clinical impact of an implication on a person's health. There are dozens if not hundreds of 
	clinical-significance value sets, generally providing an ordinal range of codes from low significance (e.g. 'benign') to high 
	significance (e.g. 'pathogenic', 'oncogenic','predictive of drug response'). </p>
	<p>While <b>evidence</b> and <b>significance</b> are orthogonal concepts, some codes conflate the two (e.g. 'expert panel consensus of strong efficacy', 
	'strong evidence refutes the clinical utility of this drug', 'case report evidence of pathogenicity'). 
	In general, using discrete evidence and significance codes allow for a more precise characterization of an implication. 
	Where an implementation is using a conflated code, we recommend communicating that code in the evidence-level field. </p>
	<p>Examples of other code sets for evidence-level and clinical-significance:</p>
	<ul>
		<li><a href="https://loinc.org/LL5356-2/">ACMG_Level of evidence</a></li>
		<li><a href="https://www.oncokb.org/levels#version=V2">Oncokb levels</a></li>	
		<li><a href="https://www.oncokb.org/therapeutic-levels#version=FDA"></a>US FDA levels</li>
		<li><a href="https://www.oncokb.org/therapeutic-levels#version=AAC"></a>AMP/ASCO/CAP levels</li>
		<li><a href="https://www.ncbi.nlm.nih.gov/clinvar/docs/clinsig/"></a>Classification on ClinVar submitted records</li>
		<li><a href="https://bioportal.bioontology.org/ontologies/NGBO/?p=classes&amp;conceptid=http://purl.obolibrary.org/obo/ngbo.owl/NGBO_6000302">Bioportal clinical variant interpretation</a></li>
		<li><a href="https://civic.readthedocs.io/en/latest/model/evidence/overview.html">CIViC Evidence</a></li>
		<li><a href="https://civic.readthedocs.io/en/latest/model/evidence/significance.html">CIViC Significance</a></li>
	</ul>


<p>
	Here are some examples of how the evidence-level component can be used (NOTE - they would be used in the appropriate, use case specific profile):
	<ul>

	<li>Coded ACMG (see <a href="https://www.acmg.net/docs/standards_guidelines_for_the_interpretation_of_sequence_variants.pdf">ACMG</a>)<br/>
			<div class="example"><pre class="json">
{
  "valueCodeableConcept": {
    "coding": [{
      "system": "https://www.acmg.org",
      "code": "PS1",
    },
    {
      "system": "https://www.acmg.org",
      "code": "PM2"
    }
    ]
  }
}
			</pre></div>
	</li>

		<li>Coded PGx (see <a href="https://www.pharmgkb.org/clinicalAnnotations">PharmGKB</a>)<br/>
			<div class="example"><pre class="json">
{
  "valueCodeableConcept": {
    "coding": [{
      "system": "https://www.pharmgkb.org/",
      "code": "Level 1A",
    }
    ]
  }
}
			</pre></div>
		</li>
		<li>Coded Somatic (see <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728662/">MVLD</a>)<br/>
			<div class="example"><pre class="json">
{
  "valueCodeableConcept": {
    "coding": [{
      "system": "https://www.clinicalgenome.org/mvld/",
      "code": "Tier1 LevelA",
    }
    ]
  }
}
			</pre></div>
		</li>
	</ul>
</p>

	<a name="Differentiating AND vs OR"> </a>
	<h3>Differentiating AND vs OR</h3>
	<p>
		There are several cases where it is necessary to differentiate 'AND' conditions (e.g. both drug X AND drug Y, in combination, are indicated in the presence of a variant) vs. 'OR' conditions (e.g., either drug X OR drug Y are indicated in the presence of a variant).

		This situation is not unique to genomic implications, and arises elsewhere within FHIR (e.g. <a href="https://www.hl7.org/fhir/search.html#combining">FHIR Search</a>) and outside of FHIR (e.g., <a href="https://www.ncbi.nlm.nih.gov/clinvar/docs/api_http/">ClinVar submission API</a> condition set). To be consistent with other precedents:
  </p>
  <p>
		Where Diagnostic and Therapeutic implications have fields with cardinality > 1, the inclusion of multiple values within a field SHALL indicate an 'AND' condition. An 'OR' condition SHALL be represented by multiple observation instances.
	</p>
	<p>
		Implication fields affected by this guidance include:
	</p>
		<p>
		<a href="StructureDefinition-molecular-consequence.html">Molecular consequences</a>: derivedFrom, evidence-level, feature-consequence.
	</p>
	<p>
		<a href="StructureDefinition-therapeutic-implication.html">Therapeutic implications</a>: derivedFrom, evidence-level, therapeutic-implication, phenotypic-treatment-context, medication-assessed, therapy-assessed.
	</p>
	<p>
		<a href="StructureDefinition-diagnostic-implication.html">Diagnostic implications</a>: derivedFrom, evidence-level, predicted-phenotype, genomic-risk-assessment.
	</p>
	<p>
		As an example, assume Variant X is pathogenic for Disease Y AND Disease Z in combination. This would be a single diagnostic implication, where predicted-phenotype is a list containing both Disease Y and Disease Z. If on the other hand, Variant X might be pathogenic for Disease Y alone, or Disease Z alone, this would be two diagnostic implications, one containing a predicted-phenotype of Disease Y, and the other containing a predicted-phenotype of Disease Z.
	</p>

</div>